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  The linear no-threshold (LNT) model of ionizing-radiation-induced cancer is based
on the assumption that every radiation dose increment constitutes increased cancer risk
for humans. The risk is hypothesized to increase linearly as the total dose increases. While
this model is the basis for radiation safety regulations, its scientific validity has been ques-
tioned and debated for many decades. The recent memorandum of the International
Commission on Radiological Protection admits that the LNT-model predictions at low
doses are “speculative, unproven, undetectable and ‘phantom’.” Moreover, numerous
experimental, ecological, and epidemiological studies show that low doses of sparsely-ion-
izing or sparsely-ionizing plus highly-ionizing radiation may be beneficial to human health
(hormesis/adaptive response). The present LNT-model-based regulations impose exces-
sive costs on the society. For example, the median-cost medical program is 5000 times
more cost-efficient in saving lives than controlling radiation emissions. There are also lives
lost: e.g., following Fukushima accident, more than 1000 disaster-related yet non-radi-
ogenic premature deaths were officially registered among the population evacuated due
to radiation concerns. Additional negative impacts of LNT-model-inspired radiophobia
include: refusal of some patients to undergo potentially life-saving medical imaging; dis-
couragement of the study of low-dose radiation therapies; motivation for radiological ter-
rorism and promotion of nuclear proliferation.
Key Words: low-dose radiation, risk, hormesis, adaptive response
With the linear no-threshold (LNT) model of radiation-induced can-
cers it is assumed that each ionizing radiation dose increment, no matter
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how small, constitutes an increase in the cancer risk to humans. The risk
is assumed to increase linearly as total dose increases, with an adjustment
made to the slope of the dose-response curve for the reduced risk at
lower dose rates. Typically, the slope is scaled down by a factor of 2 for
very low dose rates (e.g. for Fukushima down-winders) in comparison to
the slope for high dose rates (e.g. Hiroshima and Nagasaki).
Where mixtures of different radiations are involved (e.g., alpha, beta,
and gamma), special radiation weighting factors (RWFs) are used to obtain
a weighted dose named equivalent dose. RWF values are based on relative
biological effectiveness (RBE) and vary from 1 (X, beta, gamma) to 20
(alpha). The RBE values come from animal and in vitro studies and vary
a lot for different conditions. Where different organs are involved, tissue
weighting factors are also used, which relate to differing tissue sensitivities;
the resulting overall dose assigned to an individual applies to the whole
body and is called effective dose. Effective dose has the following property:
if e.g., only the lung is irradiated and the risk of lung cancer is 0.01, then
the effective dose is the hypothetical uniform gamma-ray dose to the total
body that results in the same risk (0.01) of cancer, when all cancer types
are considered. The partitioning of the risk between cancer types is based
on LNT and assigned uncertain tissue weighting factors.
Both equivalent dose and effective dose are expressed in units of siev-
ert (Sv). Small effective doses on average (e.g., 0.1 mSv = 0.0001 Sv) to
each member of a large population (e.g., 1 million persons downwind of
Fukushima) are added to obtain a large collective dose (e.g., 0.1 mil-
lisievert × 1 million persons = 100,000 person-millisieverts), a hypotheti-
cal value which is then multiplied by a risk coefficient to predict hypo-
thetical cancer cases or cancer deaths for the population. It is important
to recognize that the risk coefficient makes sense and both equivalent
dose and effective dose are directly related to cancer risk only when dose-
response relationships of interest are of the LNT type. Thus, collective
dose is a LNT-hypothesis-related hypothetical value.
The LNT model in a more complex form (e.g., weighted average of
absolute and relative risk forms) is presently relied on for cancer risk
assessment. The LNT model is also relied on by regulatory agencies, and
as such it has become the basis for radiation safety regulations. Moreover,
the LNT model is widely accepted by the general public. However, the sci-
entific validity of this model has never been proven and has been seri-
ously questioned and debated for many decades (Taylor 1980;
Feinendegen 1991; Jaworowski 1999; Tanooka 2001; Sakai et al. 2003;
Scott 2008; Tubiana et al. 2009; Cuttler 2010; Fornalski and Dobrzyński
2010; Sanders 2010; Feinendegen et al. 2013). The absence of scientific
consensus has always been officially acknowledged, including by the US
Congress Office of Technology Assessment (OTA 1979). The recent
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memorandum of the ICRP (International Commission on Radiological
Protection) Task Group (Gonzalez et al. 2013) states that:
“While prudent for radiological protection, the LNT model is not universally
accepted as biological truth, and its influence and inappropriate use to attrib-
ute health effects to low dose exposure situations is often ignored...
Speculative, unproven, undetectable and ‘phantom’ numbers are obtained by
multiplying the nominal risk coefficients by an estimate of the collective dose
received by a huge number of individuals theoretically incurring very tiny doses
that are hypothesized from radioactive substances released into the environ-
ment.” (Highlights are by the authors).
Thus, the Task Group of the ICRP, one of the main bodies promoting
the LNT model, admits that LNT predictions at low doses (up to 100
mSv) are “speculative, unproven, undetectable and ‘phantom’,” raising the rea-
sonable question of how such a model can be “prudent for radiological pro-
tection” and be justifiably used in low-dose radiation risk assessment. The
supporters of the LNT model claim that its use is “conservative” and
should be continued until the model is proven to be untrue. They claim
that in the field of safety every risk factor should be considered hazardous
until proven safe, like every firearm should be considered loaded until
proven unloaded. The case of radiation protection is quite different, as
discussed below.
Numerous studies (experimental, epidemiological, and ecological)
have shown that low doses of ionizing radiation can be beneficial to
health (Feinendegen et al. 2004; Jaworowski 2008; Tubiana et al. 2009;
Sanders 2010; Thompson 2011). For example, in an epidemiological
study of cancer among nuclear industry workers, the rate of cancer mor-
tality (as well as overall mortality) among the workers was substantially
lower than in the reference population (Sponsler and Cameron 2005). In
an epidemiological study of lung cancer association with residential
radon exposure, low doses of radiation were found to prevent the occur-
rence of some lung cancers (Thompson 2011). Also, the healing proper-
ties of radon from spas have been utilized for centuries before people
heard the word “radiation” and radon treatment is widely accepted by
both the medical community and patients in Europe (Erickson 2007).
Radon therapy is also popular in Japan and to a lesser extent in the
United States. The lack of popularity in the United States appears to
relate at least in part to the claim by the U. S. Environmental Protection
Agency that residential radon causes thousands of lung cancer deaths
annually among U. S. citizens.
The low-dose radiation benefits mentioned above and numerous oth-
ers (Mitsunobu et al. 2003; Boreham et al. 2007; Lacoste-Colin et al. 2007;
Y. Socol and others
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Liu 2007; Cohen 2008; Nakatsukasa et al. 2008; Scott 2008, 2011; Scott et
al. 2008; Sanders 2010, Thompson 2011; Doss 2012; Sanders 2012; Scott
and Dobrzyński 2012; Ulsh 2012; Calabrese 2013; Feinendegen et al. 2013;
Nomura et al. 2013) comprise emerging scientific support for the appli-
cation of radiation hormesis/adaptive response for a variety of health
benefits.
The present LNT-based regulations impose excessive costs to the soci-
ety, effectively leading to loss, rather than saving, of life. For example:
• According to the researchers from the Harvard School of Public Health
(Graham 1995), spending $100,000,000 per year on controlling radia-
tion emissions might save 1 life-year per year, if the LNT model were
valid, while life-saving medical program median cost is $19,000 per life-
year saved. Another study concluded that costs of radiation protection
are about 5000 times higher than the cost of protection of workers from
all other and much more probable events (Inhaber 2001).
• At Chernobyl and Fukushima, compulsory relocation (ordered by the
authorities on the basis of ICRP recommendations which are based on
the LNT model predictions) led to social destruction, which caused sig-
nificant emotional/psychological problems and life-shortening. After
Fukushima alone, more than 1000 non-radiogenic disaster-related pre-
mature deaths were officially registered among the evacuated popula-
tion during the first year after the accident (Saji 2013). If not evacuated,
these people would have received low doses of radiation that would
have led, according to the LNT model, to shortening of life expectancy
by less than one week (Socol et al. 2013) – while even this estimation is
“speculative, unproven, undetectable and ‘phantom’” according to the
above-mentioned ICRP Task Group memorandum.
There are additional aspects of human cost because of the LNT
model and the associated radiophobia – an irrational fear of radiation
hazards:
• “Predictions of hypothetical cancer incidence and deaths ... cause some patients
and parents to refuse medical imaging procedures, placing them at substantial
risk by not receiving the clinical benefits of the prescribed procedures” (AAPM
2011).
• Present policy significantly dissuades the study of low-dose radiation
therapies for beneficial effects in medicine, whereas animal studies
have shown potential for treatment of diseases for which presently no
treatments are available, e.g., treatment of Alzheimer’s disease using
low-dose radiation (Wei et al. 2012).
• After Chernobyl, there were more than 100,000 unnecessary abortions
of pregnancies among females that received negligible radiation doses
Ethical issues of current policies
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(or no dose at all) associated with the reactor accident (Ketchum
1987).
• Finally, unrelated to medical treatment but related to ethics, radiopho-
bia contributes to motivating radiological terrorism and promoting nu-
clear proliferation (Socol et al. 2013).
In light of the above we suggest that the scientific community address
these questions:
1. Can the LNT model, whose predictions are “speculative, unproven,
undetectable and ‘phantom’”, be “prudent for radiological protec-
tion” and “accurate for low-dose-risk estimation”?
2. Doesn’t the high human cost of LNT-model-based policy necessitate
serious reconsideration of this policy?
3. Should the present approval procedure for using low-dose radiation
in medical research/treatment be eased in cases of cancer, autoim-
mune disease, diabetes, bronchial asthma, Parkinson’s, Alzheimer’s
and other presently-incurable diseases associated with major suffer-
ing?
4. Should the medical community attend to debunking radiophobia by
explaining the evidence against the LNT model?
5. Should bio-medical research of low-dose radiation be given a priority
in order to resolve the existing controversy about negative/zero/pos-
itive carcinogenic effect?
Note: This paper is an adaptation of a letter recently submitted to the
Israeli Bioethics Commission by some of the authors (Yehoshua Socol,
Ludwik Dobrzyński, Mohan Doss, Ludwig E. Feinendegen, Marek K.
Janiak, Charles L. Sanders, Brant Ulsh, Alexander Vaiserman). All
authors of this paper are members of Scientists for Accurate Radiation
Information (SARI) whose mission is to help prevent unnecessary, radiation-
phobia-related deaths, morbidity, and injuries associated with nuclear/radiological
emergencies through countering phobia-promoting misinformation spread by
alarmists via the news and other media including journal publications.
DISCLAIMER: This paper represents the professional opinions of the
authors, and does not necessarily represent the views of their affiliated
institutions.
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